Work

Immunotherapy: MULTI-TUMOR ASSOCIATED ANTIGEN SPECIFIC T CELL (TAA-T) THERAPY TO TREAT PEDIATRIC PATIENTS WITH HIGH-RISK CNS TUMORS: THE REMIND TRIAL

Year: 2023

Type: article

Source: Cytotherapy

DOI: 10.1016/s1465-3249(23)00181-0

Authors: A. Geiger, R. Diccocio, M. Fortiz, M. Grant, H. Lang, A. Shibli, A. Datar, E. Reynolds, C. Lazarski, M. Jensen-Wachspress, G. Pezzella, D. Ayala-Gomez, J. Tanna, F. Hoq, P. Hanley, L. Kilburn, B. Rood, R. Packer, C. Cruz, E. Hwang, C. Bollard

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4376112411

FWCI:

Cites:

Cited by:

Related to: 10